Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
Breast Cancer Research and Treatment
|
July 9, 2014
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
Carey Anders, Allison M Deal, Vandana Abramson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
David M Routman, Sunil Kumar, Bisham S Chera, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
NPJ Precision Oncology
|
April 30, 2026
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection
Hidekazu Oyoshi, Hideaki Bando, Riu Yamashita, et al.
NPJ Precision Oncology
|
January 19, 2026
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Yoshiaki Nakamura, Johannes G Reiter, Prashanthi Natarajan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2016
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A Freedman, Rebecca S Gelman, Jeffrey S Wefel, et al.
Cancer
|
February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer
Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Nature Communications
|
December 9, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors
Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf, et al.
Mayo Clinic Proceedings
|
June 26, 2019
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
Stephen J Russell, Dusica Babovic-Vuksanovic, Alice Bexon, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
Breast Cancer Research and Treatment
|
July 9, 2014
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
Carey Anders, Allison M Deal, Vandana Abramson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma
David M Routman, Sunil Kumar, Bisham S Chera, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2026
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
Neil Carleton, Alexander C Chang, Fangyuan Chen, et al.
NPJ Precision Oncology
|
April 30, 2026
Preoperative ctDNA and tumor volume predict colorectal cancer recurrence after metastasis resection
Hidekazu Oyoshi, Hideaki Bando, Riu Yamashita, et al.
NPJ Precision Oncology
|
January 19, 2026
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Yoshiaki Nakamura, Johannes G Reiter, Prashanthi Natarajan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2016
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A Freedman, Rebecca S Gelman, Jeffrey S Wefel, et al.
Cancer
|
February 29, 2024
Detection of circulating tumor DNA with ultradeep sequencing of plasma cell-free DNA for monitoring minimal residual disease and early detection of recurrence in early-stage lung cancer
Aaron C Tan, Gillianne G Y Lai, Stephanie P L Saw, et al.
Nature Communications
|
December 9, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors
Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf, et al.
Mayo Clinic Proceedings
|
June 26, 2019
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
Stephen J Russell, Dusica Babovic-Vuksanovic, Alice Bexon, et al.
Page
of 16